Equities

Global Pharmatech Inc

GBLP:PKC

Global Pharmatech Inc

Actions
  • Price (USD)0.35
  • Today's Change0.00 / 0.00%
  • Shares traded750.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of May 24 2024 14:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2007200720062005
ASSETS
Cash And Short Term Investments5.455.600.69
Total Receivables, Net1.762.042.44
Total Inventory0.861.541.11
Prepaid expenses0.010.020.04
Other current assets, total----1.00
Total current assets8.089.195.28
Property, plant & equipment, net5.136.836.73
Goodwill, net------
Intangibles, net0.130.120.17
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets131612
LIABILITIES
Accounts payable----0.07
Accrued expenses------
Notes payable/short-term debt0.2700
Current portion long-term debt/capital leases2.460.260.05
Other current liabilities, total0.970.740.75
Total current liabilities4.191.421.42
Total long term debt02.622.53
Total debt2.742.882.58
Deferred income tax------
Minority interest1.101.000.98
Other liabilities, total------
Total liabilities5.305.044.93
SHAREHOLDERS EQUITY
Common stock0.000.000.00
Additional paid-in capital11116.74
Retained earnings (accumulated deficit)(4.02)(0.72)0.51
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.700.46--
Total equity8.04117.25
Total liabilities & shareholders' equity131612
Total common shares outstanding232318
Treasury shares - common primary issue------
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.